How appropriate is asthma therapy in general practice?

Fundamental and Clinical Pharmacology

Volumn 19, Issue 1, 2005, Pages 107-115

  Laforest, Laurent ^a   Pacheco, Yves ^a   Bousquet, Jean ^b   Kocevar, Vasilisa Sazonov ^c   Yin, Don ^c   Van Ganse, Eric ^a  

^a HOSPICES CIVILS DE LYON   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Asthma; Management; Therapy

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; ANTITUSSIVE AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA LACTAM ANTIBIOTIC; BUDESONIDE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CORTICOSTEROID; CROMOGLYCATE DISODIUM; EXPECTORANT AGENT; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE; THEOPHYLLINE;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; BODY BURDEN; CONFIDENCE INTERVAL; DATA BASE; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE COURSE; DISEASE MARKER; DRUG DOSE REGIMEN; FEMALE; FRANCE; GENERAL PRACTICE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOMES RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH; QUESTIONNAIRE; RETROSPECTIVE STUDY; SMOKING; STATISTICAL ANALYSIS;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ASTHMA; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FAMILY PRACTICE; FEMALE; GLUCOCORTICOIDS; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RESPIRATORY SYSTEM AGENTS; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS;

EID: 13444249764     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2004.00302.x     Document Type: Article

References (30)

1. Janson C., Chinn S., Jarvis D., Burney P. Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey. Eur. Respir. J. (1997) 10 1795-1802.
2. Jepson G., Butler T., Gregory D., Jones K. Prescribing patterns for asthma by GP in six European countries. Respir. Med. (2000) 94 578-583.
3. Lagerlov P., Veninga C.C., Muskova M. et al. Asthma management in five European countries: doctors' knowledge, attitudes and prescribing behaviour. Drug Education Project (DEP) group. Eur. Respir. J. (2000) 15 25-29.
4. Legorreta A.P., Christian-Herman J., O'Connor R.D., Hasan M.M., Evans R., Leung K.M. Compliance with national asthma management guidelines and specialty care: a health maintenance organization experience. Arch. Intern. Med. (1998) 158 457-464.
5. Roghmann M.C., Sexton M. Adherence to asthma guidelines in general practices. J. Asthma (1999) 36 381-387.
6. Bousquet J., Knani J., Henry C. et al. Undertreatment in a nonselected population of adult patients with asthma. J. Allergy Clin. Immunol. (1996) 98 514-521.
7. Singh A.K., Woodruff P.G., Ritz R.H., Mitchell D., Camargo C.A. Jr. Inhaled corticosteroids for asthma: are emergency departments visits a missed opportunity for prevention? Am. J. Emerg. Med. (1999) 17 144-147.
8. Yuksel N., Ginther S., Man P., Tsuyuki R.T. Underuse of inhaled corticosteroids in adults with asthma. Pharmacotherapy (2000) 20 387-393.
9. Neville R.G., Hoskins G., Smith B., Clark R.A. How GP manage acute asthma attacks. Thorax (1997) 52 153-156.
10. Kljakovic M., Mahadevan G. General practitioner prescribing of antibiotics for asthma. Br. J. Gen. Pract. (1998) 48 1773-1774.
11. Van Ganse E., Van der Linden P., Leufkens H.G.M., Vincken W., Ernst P. Antiallergic and antitussive medications in asthma: extent of use, and relationship to exacerbations. Therapie (1996) 51 373-377.
12. Van Ganse E., Boissel J.P., Gormand F., Ernst P. Level of control and hospital contacts in persistent asthma patients. J. Asthma (2001) 38 637-643.
13. Rabe K.F., Vermeire P.A., Soriano J.B., Maier W.C. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur. Respir. J. (2000) 16 802-807.
14. Van Ganse E., Laforest L., Pietri G. et al. Persistent asthma: disease control, resource utilisation, and direct costs. Eur. Respir. J. (2002) 20 1-8.
15. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention NHLBI/WHO WORKSHOP report (January 1995). National Institute of Health, Bethesda Maryland, USA.
16. Jones K., Gruffydd-Jones K. Management of acute asthma attacks associated with respiratory tract infection: a postal survey of general practitioners in the U.K. Respir. Med. (1996) 90419-425.
17. Cockcroft D.W., Swystun V.A. Asthma control versus asthma severity. J. Allergy Clin. Immunol. (1996) 98 1016-1018.
18. Van Ganse E., Kaufman L., Derde M.P., Yernault J.C., Delaunois L., Vincken W. Effects of antihistamines in adult asthma: a meta-analysis of clinical trials. Eur. Respir. J. (1997) 10 2216-2224.
19. Hirschmann J.V. Antibiotics for common respiratory tract infections in adults. Arch. Intern. (2002) 162 256-264.
20. Beasley R., Coleman E.D., Hermon Y., Holst P.E., O'Donnell T.V., Tobias M. Viral respiratory tract infection and exacerbations of asthma in adult patients. Thorax (1988) 43 679-683.
21. Bronzwaer S.L., Cars O., Buchholz U. et al. European Antimicrobial Resistance Surveillance System. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg. Infect. Dis. (2002) 8 278-282.
22. Glauber J.H., Fuhlbrigge A.L., Finkelstein J.A., Homer C.J., Weiss S.T. Relationship between asthma medication and antibiotic use. Chest (2001) 120 1485-1492.
23. Liard R., Segala C., Beguin F.X. et al. Asthma in private pneumology practice. Rev. Mal. Respir. (1997) 14 295-304.
24. Stroupe K.T., Gaskins D., Murray M.D. Health-care costs of inner-city patients with asthma. J. Asthma (1999) 36 645-655.
25. Cote J., Bowie D.M., Robichaud P., Parent J.G., Battisti L., Boulet L.P. Evaluation of two different educational interventions for adult patients consulting with an acute asthma exacerbation. Am. J. Respir. Crit. Care Med. (2001) 163 1415-1419.
26. Legorreta A.P., Leung K.M., Berkbigler D., Evans R., Liu X. Outcomes of a population-based asthma management program: quality of life, absenteeism, and utilization. Ann. Allergy Asthma Immunol. (2000) 85 28-34.
27. Barnes P.J. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids. Eur. Respir. J. (2002) 19 182-191.
28. FDA Talk Paper T03-62, August 14, 2003: http://www.fda. gov/bbs/topics/ANSWERS/2003/ANS01248.html (accessed 15 November 2004)
29. Mann M., Chowdhury B., Sullivan E., Nicklas R., Anthracite R., Meyer RJ. Serious asthma exacerbations in asthmatics treated with high-dose formoterol. Chest (2003) 124 70-74.
30. Adams R.J., Smith B.J., Ruffin R.E. Factors associated with hospital admissions and repeat emergency department visits for adults with asthma. Thorax (2000) 55 566-573.